Uzm. Dr. Selçuk Cemil ÖZTÜRK

Deneyim

MEMORIAL ANKARA HASTANESİ

Medikal Onkoloji Uzmanı
2017 - Halen, Ankara/Türkiye

MEDİCANA ANKARA HASTANESİ

Medikal Onkoloji Uzmanı
2015 - 2015, Ankara/Türkiye

MEDİCANA SAMSUN HASTANESİ

Medikal Onkoloji Uzmanı
2015 - 2017, Samsun/Türkiye

MEDLINE ANTALYA HASTANESİ

Medikal Onkoloji Uzmanı
2014 - 2015, Antalya/Türkiye

ADIYAMAN ÜNİVERSİTESİ EĞİTİM ARAŞTIRMA HASTANESİ

Medikal Onkoloji Uzmanı
2012 - 2014, Ankara/Türkiye

BAYINDIR HASTANESİ

İç Hastalıkları Uzmanı
1999 - 2007, Ankara/Türkiye

SEVGİ HASTANESİ

İç Hastalıkları Uzmanı
1998 - 1999, Ankara/Türkiye

Eğitim

GAZİ ÜNİVERSİTESİ TIP FAKÜLTESİ

Medikal Onkoloji Yan Dal Uzmanlık Eğitimi
2010 - 2012 , Ankara/Türkiye

ANKARA NUMUNE EĞİTİM ARAŞTIRMA HASTANESİ

Medikal Onkoloji Yan Dal Uzmanlık Eğitimi
2009 - 2010 , Ankara/Türkiye

S.B.ANKARA EĞİTİM ARAŞTIRMA HASTANESİ

İç Hastalıkları Uzmanlık Eğitimi
1993 - 1998 , Ankara/Türkiye

ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ

Tıp Doktoru Eğitimi
1984 - 1992 , Ankara/Türkiye

Bilimsel Yayınları

-Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.

Turan N, Benekli M, Unal OU, Unek İT, Tastekin D, Dane F, Algın E, Ulger S, Eren T, Topcu TO, Turkmen E, Babacan NA, Tufan G, Urakci Z, Ustaalioglu BO, Uysal OS, Ercelep OB, Taskoylu BY, Aksoy A, Canhoroz M, Demirci U, Dogan E, Berk V, Balakan O, Ekinci AŞ, Uysal M, Petekkaya İ, Ozturk SC, Tonyalı Ö, Çetin B, Aldemir MN, Helvacı K, Ozdemir N, Oztop İ, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO)..

Chin J Cancer Res. 2015 Aug;27(4):408-16. doi: 10.3978/j.issn.1000-9604.2015.08.03.

2-Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers.

Baykara M, Benekli M, Ekinci O, Irkkan SC, Karaca H, Demirci U, Akinci MB, Unal OU, Dane F, Turkoz FP, Balakan O, Eser EP, Ozturk SC, Ozkan M, Oksuzoglu B, Sevinc A, Demir N, Harputluoglu H, Yalcin B, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO)..

J Gastrointest Surg. 2015 Sep;19(9):1565-71. doi: 10.1007/s11605-015-2888-y. Epub 2015 Jul 16.

3-Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.

Turan N, Benekli M, Dane F, Unal OU, Kara HV, Koca D, Balvan O, Eren T, Tastekin D, Helvaci K, Berk V, Demirci U, Ozturk SC, Dogan E, Cetin B, Kucukoner M, Tonyali O, Tufan G, Oztop I, Gumus M, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO)..

Thorac Cancer. 2014 Sep;5(5):398-404. doi: 10.1111/1759-7714.12107. Epub 2014 Aug 25.

Select item 24444261

4-Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).

Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Balakan O, Cınkır HY, Alıcı S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan A.

Int Surg. 2014 Jan-Feb;99(1):2-7. doi: 10.9738/INTSURG-D-13-00010.

5-Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical Oncology.

Inal A, Akman T, Yaman S, Ozturk SC, Geredeli C, Bilici M, Inanc M, Harputoglu H, Demirci U, Suner A, Cınkır HY, Alıcı S, Colak D, Sonmez OU, Goksel G, Dogu GG, Engin H, Unal OU, Tamozlu T, Buyukberber S, Boruban CM, Isıkdogan A.

Ann Ital Chir. 2013 Mar-Apr;84(2):143-8.

6-Clinicopathological features in bilateral breast cancer.

Baykara M, Ozturk SC, Buyukberber S, Helvaci K, Ozdemir N, Alkis N, Berk V, Koca D, Coskun U, Oksuzoglu B, Uncu D, Arpaci E, Ustaalioglu BO, Demirci U, Kucukoner M, Dogu GG, Alici S, Akman T, Ozkan M, Aslan UY, Durnali AG, Benekli M.

Asian Pac J Cancer Prev. 2012;13(9):4571-5.

7-Sunitinib- and sorafenib-induced nephrotic syndrome in a patient with gastrointestinal stromal tumor.

Turan N, Benekli M, Ozturk SC, Inal S, Memis L, Guz G, Cetin B, Buyukberber S.

Ann Pharmacother. 2012 Oct;46(10):e27. doi: 10.1345/aph.1R160. Epub 2012 Oct 2.

8-Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents.

Cetin B, Kaplan MA, Berk V, Ozturk SC, Benekli M, Isıkdogan A, Ozkan M, Coskun U, Buyukberber S.

Asian Pac J Cancer Prev. 2012;13(3):1059-63.

9-Lomber Omurgaya Yayılan Bir Glioblastoma Multiforme Olgusu

A Glioblastoma Multiforme Case Spread to Lomber Spine

Selçuk Cemil Öztürk, Gülnihal Tufan, Mustafa Benekli, Nedim Turan

Acta Oncologica Turcica 2015; 44: 2-3

10-Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy

Kaya A.O,  Coskun U, Ozkan M,  Sevinc A, Yilmaz A.U,  Gumus M, Unal O.U, Ozdemir N.Y,  Alici S, Berk V,  Degerli H, Oner M.K, Ozturk C,  Kefeli U,  Camcı C.

Onkologie 2012;35:576–580

Mesleki Üyelikleri

  • Türk Tıbbi Onkoloji Derneği
  • Türk İç Hastalıkları Uzmanlık Derneği